Breddin H K, Radziwon P, Boczkowska-Radziwon B
Division of Angiology, J.W. Goethe University, Frankfurt, Germany.
Clin Lab Med. 1994 Dec;14(4):825-46.
This article examines laboratory methods that are used or may be used to monitor newly developed heparins, low-dose vitamin K antagonists, new thrombin inhibitors such as recombinant hirudin, and oligopeptide thrombin inhibitors (some of which it is hoped will be orally active), thromboxane receptor antagonists, glycoprotein IIb-IIIa inhibitors, and ticlopidine-like structures.
本文探讨了用于或可能用于监测新开发的肝素、低剂量维生素K拮抗剂、新型凝血酶抑制剂（如重组水蛭素）和寡肽凝血酶抑制剂（其中一些有望具有口服活性）、血栓素受体拮抗剂、糖蛋白IIb-IIIa抑制剂以及噻氯匹定样结构的实验室方法。
